View Author
scopus: 12243084600

Pantano, F.

(Francesco Pantano)


expression cancer patient dicer breast level rankl drosha tumor rank expression survival breast cancer patients analysis sample metastasi receptor breast cancer group table correlation bone metastasis study response prognostic dicer expression levels / european journal microarray mirna prognosis factor signi figure drosha expression levels receptor activator treatment university metastase bone metastases angiogenesi carcinoma pathway italy control outcome bone metastasis occurrence therapy regimen mucosa oncology model /rankl bevacizumab-based result bevacizumab-containing regimens rankl expression ligand activator population dataset section development tissue breast cancer specimens tumour status ficant staining prostate regulation metastatic colon drosha expression relapse clinicopathological univariate analysis bevacizumab-based therapy antibody april osteoclast dicer levels




2 Most Recent Publications

Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients (Article)
Vincenzi, B. Zoccoli, A. Correale, P. Riva, E. Russo, A.P. Loupakis, F. Falcone, A. Santini, D. Tonini, G. Schiavon, G. Iuliani, M. Pantano, F. Dell'Aquila, E. Ratta, R. Muda, A.O. Perrone, G. Brunelli, C.
2013-04-01
Receptor activator of NF-kB (rank) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients (Article)
Santini, D. Schiavon, G. La Verde, N. Caroti, C. Treilleux, I. Ruggiero, A. Perrone, G. Addeo, R. Clezardin, P. Muda, A.O. Tonini, G. Vincenzi, B. Gaeta, L. Pantano, F. Russo, A.P. Ortega, C. Porta, C. Galluzzo, S. Armento, G.
2011-05-13